High Quality GS-441524 Tablets 20mg 40mg 50mg 60mg Oral Formula for Feline FIP Veterinary Care

GS-441524 tablets are formulated for veterinary applications involving the management of feline infectious peritonitis (FIP). Designed for oral administration, they offer a practical alternative for cats requiring continuous antiviral support during extended treatment programs. The tablet form is easy to administer and is commonly selected for routine daily use under veterinary supervision.

To meet different dosing requirements, this product is available in 20mg, 40mg, 50mg, and 60mg tablet strengths. Multiple dosage options provide greater flexibility when developing treatment plans based on body weight, clinical presentation, and individual response, while also reducing the need to split tablets during administration.

Manufactured using standardized production procedures, every batch is subject to quality control measures that help ensure consistency, stability, and reliable product performance from manufacturing through delivery.

Different cats require different amounts of antiviral support during treatment. Offering four dosage strengths allows veterinarians and caregivers to select a more suitable tablet combination.

Available strengths include:

• 20mg – Appropriate for smaller cats, kittens, or gradual dose adjustment.
• 40mg – A versatile option for many routine treatment protocols.
• 50mg – Designed to reduce the number of tablets required for medium to large cats.
• 60mg – A concentrated formulation suitable for higher daily dosage requirements.

Compared with injectable formulations, tablets are convenient for daily use and may be preferred by caregivers managing long-term treatment at home.

Each production lot follows standardized manufacturing procedures with quality inspections throughout the process to promote uniformity and dependable product quality.

Protective packaging helps preserve tablet integrity during transportation and storage. Under recommended conditions, the product maintains reliable quality throughout its shelf life.

Feline infectious peritonitis is a viral disease caused by mutations of feline coronavirus (FCoV). While coronavirus infection is relatively common among cats, only a small percentage develop FIP after viral mutation.

Clinical signs vary according to the organs involved and may include several forms:

• Effusive (Wet) FIP, commonly associated with fluid accumulation in body cavities.
• Non-Effusive (Dry) FIP, affecting internal organs without significant fluid buildup.
• Ocular FIP, involving inflammation of eye tissues.
• Neurological FIP, affecting the brain and central nervous system.

Because disease progression differs between individual cats, treatment plans should always be developed according to veterinary evaluation and regular monitoring.

GS-441524 tablets are supplied for a variety of veterinary and animal care environments, including:

• Veterinary hospitals
• Companion animal clinics
• Cat rescue centers
• Professional catteries
• Veterinary distributors
• Home treatment programs supervised by veterinarians

The availability of multiple tablet strengths allows treatment plans to be adjusted as clinical conditions change during the management process.

For best product stability:

• Store at room temperature in a clean, dry place.
• Keep tablets inside the original packaging until use.
• Avoid prolonged exposure to sunlight and excessive humidity.
• Protect the product from high temperatures and moisture.

Following these recommendations helps maintain tablet quality during storage and transportation.

GS-441524 tablets are produced under controlled manufacturing standards with routine quality inspections carried out during production. Batch identification and product traceability systems help maintain consistent quality across every shipment.

From raw material selection to final packaging, attention is given to product stability, manufacturing consistency, and reliable supply for veterinary customers worldwide.

This product is intended for veterinary use only.

The appropriate tablet strength, dosage schedule, and treatment duration should be determined by a licensed veterinarian according to the cat's body weight, clinical diagnosis, and overall treatment response.